YOU STOPPED AT: "PART 5: Summary - Your Overall Prognosis Your Cancer Profile: Stage: pT2 (organ-confined)...

Your Overall Prognosis: Low-Volume pT2, Grade Group 2 Prostate Cancer

(CONTINUING FROM WHERE WE STOPPED)

---

PART 5: Summary - Your Overall Prognosis (CONTINUED)

Your Cancer Profile:

• Stage: pT2 (organ-confined)
• Grade: Gleason 3+4=7 (Grade Group 2)
• Volume: <5% (very low)
• Margins: Focal apical close (not positive)
• Surgical approach: Robot-assisted radical prostatectomy

---

Expected Outcomes Based on Current Evidence:

1) Biochemical Recurrence (PSA Rising)

5-year BCR-free survival: 75-85%

• Meaning: 75-85% chance your PSA stays undetectable
• Meaning: 15-25% chance of PSA rise

10-year BCR-free survival: 65-75%

• Meaning: 65-75% chance your PSA remains undetectable
• Meaning: 25-35% chance of PSA rise

15-year BCR-free survival: 55-65%

• Meaning: 55-65% chance your PSA remains undetectable

Clinical interpretation: Your low-volume disease puts you in the better half of intermediate-risk patients. Most men with your profile will never experience biochemical recurrence.

---

2) Metastatic Progression (Distant Spread)

5-year metastasis-free survival: 95-98%

• Meaning: 95-98% chance NO distant metastases develop
• Meaning: 2-5% chance of metastatic disease

10-year metastasis-free survival: 90-95%

• Meaning: 90-95% chance NO distant metastases develop
• Meaning: 5-10% chance of metastatic disease

15-year metastasis-free survival: 88-92%

• Meaning: 88-92% chance NO distant metastases develop
• Meaning: 8-12% chance of metastatic disease

Clinical interpretation: Your risk of ever developing distant metastases is exceptionally low — among the best possible outcomes for any prostate cancer patient.

---

3) Prostate Cancer-Specific Mortality

10-year prostate cancer-specific survival: 98-99%

• Meaning: 98-99% chance you will NOT die from prostate cancer in 10 years

15-year prostate cancer-specific survival: 95-98%

• Meaning: 95-98% chance you will NOT die from prostate cancer in 15 years

Clinical interpretation: Your risk of dying from prostate cancer is extremely low. Most men with your profile die from other causes, not prostate cancer.

---

4) Overall Survival (All Causes)

10-year overall survival: 90-95% (accounting for all causes of death)

• Meaning: 90-95% chance of being alive in 10 years

15-year overall survival: 80-88% (accounting for all causes of death)

• Meaning: 80-88% chance of being alive in 15 years

Clinical interpretation: Your life expectancy is excellent and comparable to men without prostate cancer of similar age.

---

Risk Stratification Summary:

According to NCCN Guidelines for Prostate Cancer (2024-2025) and EAU Guidelines on Prostate Cancer (2024):

| Risk Factor | Your Status | Risk Category | |---|---|---| | Stage | pT2 (organ-confined) | ✅ Favorable | | Grade | Gleason 7 (Grade Group 2) | ⚠️ Intermediate | | Volume | <5% | ✅ Very Favorable | | Margins | Focal apical close (negative) | ✅ Favorable | | Overall Risk Category | Favorable Intermediate-Risk | ✅ Better than average |

Key point: Your low volume significantly improves your prognosis compared to the average Grade Group 2 patient. You are in the better half of intermediate-risk patients.

---

PART 6: What This Means for Your Follow-Up Care

Recommended Monitoring (Based on NCCN & AUA Guidelines)

Since you had robot-assisted radical prostatectomy on [date removed] with favorable pathology:

PSA Monitoring Schedule:

Months 1-12 after surgery:

• PSA test at 6 weeks post-op (baseline)
• PSA test at 3 months post-op
• PSA test at 6 months post-op
• PSA test at 12 months post-op

Years 2-5:

• PSA test every 6 months

Years 5+:

• PSA test annually (if PSA remains undetectable)

Target PSA: <0.1 ng/mL is considered undetectable

---

What to Expect:

Immediate post-operative period (weeks 1-6):

• PSA may still be detectable as residual prostate tissue clears
• This is normal and expected

By 6-8 weeks post-op:

• PSA should become undetectable (<0.1 ng/mL)
• This indicates complete surgical removal of prostate tissue

If PSA becomes undetectable:

• ✅ Excellent sign — indicates complete cancer removal
• Continue routine monitoring per schedule above

If PSA remains detectable or rises:

• ⚠️ May indicate residual disease or microscopic spread
• Your oncologist will discuss additional imaging or treatment options

---

Additional Monitoring (Based on Your Favorable Pathology):

According to NCCN Guidelines, with your favorable intermediate-risk profile:

Imaging surveillance:

• NOT routinely recommended unless PSA rises
• Bone scan or CT only if PSA rises above 0.5-1.0 ng/mL

Digital rectal exam:

• NOT necessary after radical prostatectomy (prostate is removed)

Biomarker testing:

• Not routinely recommended for your risk profile
• May be considered if PSA recurrence develops

---

PART 7: Addressing Your Specific Questions About Pathology

Question: "How can the pathologist assess that there is 'no clear evidence of cancer extend...'"?

This relates to your focal apical close margin finding. Let me explain the pathology assessment process:

---

How Pathologists Assess Margin Status:

Step 1: Specimen Preparation

• After your prostate is removed, the pathologist receives the entire specimen
• The prostate is inked on all outer surfaces with colored dyes
• This allows the pathologist to identify which areas were at the edge of the surgical specimen

Step 2: Sectioning

• The prostate is sliced into thin sections (like slicing bread)
• Each section is placed on a glass slide
• The slides are stained with special dyes to highlight cancer cells

Step 3: Microscopic Examination

• The pathologist examines each slide under a microscope
• They look for cancer cells that reach the inked edge (positive margin)
• They look for cancer cells that are very close to the edge (close margin)
• They measure the distance from cancer to the edge

Step 4: Margin Classification

| Margin Status | Definition | What It Means | |---|---|---| | Negative margin | Cancer cells do NOT touch the inked edge | ✅ Complete removal | | Close margin | Cancer cells are <1mm from the inked edge | ⚠️ Very close but not touching | | Positive margin | Cancer cells touch or cross the inked edge | ❌ Incomplete removal |

Your situation: Focal apical close margin

• Cancer cells are very close to (but not touching) the apical edge
• This is focal (limited to one small area)